Stability of Hand Grip Strength Across a Competitive Season in Elite Male and Female Ice Hockey Players

May 6, 2026 updated by: Daniel Muder, Dalarna County Council, Sweden

Stability of Hand Grip Strength Across a Competitive Season in Elite Male and Female Ice Hockey Players: A Prospective Longitudinal Observational Cohort Study

This study examines how hand grip strength changes over the course of a competitive ice hockey season in elite male and female players.

Hand grip strength is a simple and widely used measure of upper-body strength and functional capacity. It is often used in sports science and clinical settings, but it is unclear whether grip strength remains stable throughout a season or changes depending on training load, match exposure, and fatigue.

In this study, elite ice hockey players from Swedish teams will have their grip strength measured at four timepoints during one season: pre-season, early season, mid-season, and late season. Both dominant and non-dominant hand strength will be assessed using a standardized dynamometer and protocol.

The main purpose is to determine how much grip strength varies within individual players over time and whether a single measurement can be considered representative of a player's true strength level across a season. The study will also evaluate the reliability of grip strength measurements and whether observed changes are large enough to be meaningful in a clinical or performance context.

No intervention is performed, and all measurements are non-invasive and conducted as part of routine testing environments within participating teams.

Study Overview

Status

Not yet recruiting

Detailed Description

This is a prospective longitudinal observational cohort study designed to evaluate within-season variability and measurement stability of maximal isometric hand grip strength in elite ice hockey players.

Hand grip strength is widely used as a surrogate marker of upper-limb strength and general neuromuscular capacity. Although its reliability has been well described in clinical and general athletic populations when measured using standardized protocols, limited evidence exists regarding its temporal stability in elite collision sport athletes over an entire competitive season. In particular, it remains unclear whether grip strength behaves as a stable individual characteristic or whether it is influenced by seasonal training load, match congestion, fatigue, or adaptation effects.

The study will include elite male and female ice hockey players recruited from Swedish top-level teams. Participants will undergo repeated standardized grip strength assessments at four predefined timepoints across one competitive season: pre-season baseline, early mid-season, late mid-season, and pre-playoff/end-of-season phase. All measurements will be performed using a calibrated hand dynamometer following a standardized protocol based on established clinical measurement guidelines, including consistent body positioning, handle adjustment, and repeated maximal trials for both dominant and non-dominant hands. Mean values from repeated trials will be used for analysis.

To reduce measurement variability, all testing will be conducted by trained assessors using harmonized instructions across participating teams. Where possible, testing sessions will be scheduled to minimize acute fatigue effects by ensuring a standardized recovery period following matches or high-intensity training sessions.

The primary analytical focus is within-subject variability of grip strength across the season, quantified using measures of dispersion and reliability, including coefficient of variation (CV%), within-subject standard deviation, and intraclass correlation coefficients (ICC). Additional analyses will estimate measurement error (standard error of measurement) and minimal detectable change (MDC95) to determine the smallest meaningful change in grip strength that exceeds expected measurement noise.

Longitudinal changes in grip strength across the season will be assessed using mixed-effects statistical models to account for repeated measures within individuals and potential group-level effects such as sex and playing level.

The study does not involve any interventions, treatment allocation, or experimental manipulation. All assessments are non-invasive and conducted within routine team environments. The findings are intended to inform interpretation of grip strength in athletic monitoring, rehabilitation contexts, and performance evaluation, specifically whether single timepoint measurements can be reliably used for comparison against normative data or whether seasonality must be considered in clinical and performance decision-making.

Study Type

Observational

Enrollment (Estimated)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Dalarna County
      • Falun, Dalarna County, Sweden, 79182
        • Center for Clinical Research Dalarna, Uppsala University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

150

Description

Inclusion Criteria:

  • Contracted elite ice hockey players in participating Swedish teams (SHL, HockeyAllsvenskan, SDHL or equivalent top division)
  • Male or female players competing at elite level
  • Available for testing at all predefined measurement timepoints across the season
  • Able to perform maximal hand grip strength testing
  • Provides informed consent

Exclusion Criteria:

  • Acute hand or wrist injury at baseline preventing maximal grip strength testing
  • Any condition during the study period preventing completion of repeated grip strength assessments
  • Inability to participate in all scheduled measurement sessions
  • Refusal to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Elite Ice Hockey Players Cohort
Elite male and female ice hockey players from Swedish top-level teams (SHL, HockeyAllsvenskan, SDHL). Participants undergo repeated standardized measurements of hand grip strength across four predefined timepoints during one competitive season (pre-season, early season, mid-season, and pre-playoff/end-of-season). The same individuals are followed longitudinally to assess within-subject variability and stability of grip strength over time.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Within-Subject Variability of Hand Grip Strength
Time Frame: From baseline (pre-season) to end of season (pre-playoff), up to 8 months
Within-subject variability of maximal isometric hand grip strength across a competitive season in elite ice hockey players, expressed as coefficient of variation (CV%) across repeated measurements.
From baseline (pre-season) to end of season (pre-playoff), up to 8 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Test-Retest Reliability of Hand Grip Strength
Time Frame: From baseline (pre-season) to end of season (pre-playoff), up to 8 months
Reliability of repeated grip strength measurements across the season assessed using intraclass correlation coefficient (ICC).
From baseline (pre-season) to end of season (pre-playoff), up to 8 months
Within-Subject Standard Deviation of Grip Strength
Time Frame: From baseline (pre-season) to end of season (pre-playoff), up to 8 months
Absolute within-player variability in grip strength across the competitive season.
From baseline (pre-season) to end of season (pre-playoff), up to 8 months
Standard Error of Measurement (SEM)
Time Frame: From baseline (pre-season) to end of season (pre-playoff), up to 8 months
Measurement error of grip strength across repeated seasonal assessments.
From baseline (pre-season) to end of season (pre-playoff), up to 8 months
Minimal Detectable Change (MDC95)
Time Frame: From baseline (pre-season) to end of season (pre-playoff), up to 8 months
Smallest change in grip strength considered beyond measurement error with 95% confidence.
From baseline (pre-season) to end of season (pre-playoff), up to 8 months
Seasonal Change in Grip Strength
Time Frame: From baseline (pre-season) to end of season (pre-playoff), up to 8 months
Systematic changes in maximal grip strength across the competitive season assessed using longitudinal mixed-effects models.
From baseline (pre-season) to end of season (pre-playoff), up to 8 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

April 30, 2027

Study Completion (Estimated)

December 31, 2027

Study Registration Dates

First Submitted

April 30, 2026

First Submitted That Met QC Criteria

April 30, 2026

First Posted (Actual)

May 6, 2026

Study Record Updates

Last Update Posted (Actual)

May 11, 2026

Last Update Submitted That Met QC Criteria

May 6, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • EPM will be added later.

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Any data shared with colleagues or collaborating researchers will be fully anonymized or pseudonymized to protect participant privacy in accordance with GDPR regulations. Data transfers will occur under strict confidentiality agreements, and all parties will adhere to applicable data protection laws to ensure the security and privacy of personal information. We will act in accordance with the ethical approval granted by the Swedish Ethical Review Authority (EPM) and comply with all relevant local policies regarding data protection.

IPD Sharing Time Frame

From the publication of the protocol and for 10 years thereafter.

IPD Sharing Access Criteria

Access to individual participant data is typically restricted to authorized researchers involved in the study or approved collaborators under strict confidentiality and data protection agreements.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Grip Strength

Subscribe